Mabvax Therapeutics Holdings
San Diego, US · Delaware corporation
Founders & leadership
JD
J. David HansenPresident, Chief Executive Officer and Chairman of the Board
GH
Gregory HansonChief Financial Officer
MM
Michael M. WickExecutive
WP
William P. KaplanExecutive
SR
Steven R. SchowExecutive
WK
Wendy K. WeeExecutive
Board
JR
Jeffrey RavetchBoard director
KC
Kenneth CohenBoard director
RH
Robert HoffmanBoard director
PL
Philip LivingstonBoard director
TV
Thomas VarranoBoard director
PM
Paul MaierBoard director
Reported raises · per SEC filings
Form D private placements$25M disclosed across 5 rounds · 2014–2018
▶$830KraisedMay 2018 · 11 investors · BiotechnologyRule 506(b)
▶$830KraisedMay 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul V. MaierDirector
- Thomas C. VarvaroDirector
- J. David HansenExecutive Officer, Director
- Philip O. LivingstonDirector
- Gregory P. HansonExecutive Officer
- Paul ResnickExecutive Officer
- Jeffrey F. EisenbergDirector
- Kenneth M. CohenDirector
- Paul W. MaffuidExecutive Officer
- Offering amount
- $860K
- Amount sold
- $830K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.8MraisedFeb 2018 · 13 investors · BiotechnologyRule 506(b)
▶$2.8MraisedFeb 2018 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas VarvaroDirector
- Paul ResnickExecutive Officer
- Philip LivingstonDirector
- Kenneth CohenDirector
- Paul MaierDirector
- Gregory HansonExecutive Officer
- Paul MaffuidExecutive Officer
- J. David HansenExecutive Officer, Director
- Jeffrey EisenbergDirector
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.6MraisedApr 2015 · 49 investors · BiotechnologyRule 506(b)
▶$11.6MraisedApr 2015 · 49 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey RavetchDirector
- Kenneth CohenDirector
- Gregory HansonExecutive Officer, Director
- Robert HoffmanDirector
- J. David HansenExecutive Officer, Director
- Philip LivingstonDirector
- Thomas VarranoDirector
- Paul MaierDirector
- Offering amount
- $15M
- Amount sold
- $11.6M
- Sales commissions
- $573.7K
- Placement agents
- Laidlaw & Company, Ltd., Palladium Capital Advisors, LLC
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.2MraisedJul 2014 · 55 investors · BiotechnologyRule 506(b)
▶$5.2MraisedJul 2014 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philip O. LivingstonExecutive Officer, Director
- Kenneth M. CohenDirector
- Jeffrey V. RavetchDirector
- J. David HansenExecutive Officer, Director
- Michael WickDirector
- Gregory P. HansonExecutive Officer
- Paul MaierDirector
- Jim J. AntonopoulosDirector
- Offering amount
- $5.2M
- Amount sold
- $5.2M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.6MraisedMay 2014 · 3 investors · BiotechnologyRule 506(b)
▶$4.6MraisedMay 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward W. CantrallDirector
- Michael M. WickExecutive Officer, Director
- William P. KaplanExecutive Officer
- Richard B. NewmanDirector
- Steven R. GoldringDirector
- Steven R. SchowExecutive Officer
- Wendy K. WeeExecutive Officer
- Offering amount
- $4.6M
- Amount sold
- $4.6M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Mabvax Therapeutics Holdings?
- Mabvax Therapeutics Holdings was founded by J. David Hansen.
- How much funding has Mabvax Therapeutics Holdings raised?
- Mabvax Therapeutics Holdings has disclosed $25M raised across 5 rounds.
- Where is Mabvax Therapeutics Holdings headquartered?
- Mabvax Therapeutics Holdings is headquartered in San Diego, US.